Frank E Harrell
Overview
Explore the profile of Frank E Harrell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1008
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Freiberg J, Siemann J, Qian E, Ereshefsky B, Hennessy C, Stollings J, et al.
Trials
. 2024 Dec;
25(1):854.
PMID: 39732716
Background: Vancomycin, an antibiotic with activity against methicillin-resistant Staphylococcus aureus (MRSA), is frequently included in empiric treatment for community-acquired pneumonia (CAP) despite the fact that MRSA is rarely implicated in...
2.
Lindsell C, Shotwell M, Anstrom K, Berry S, Brittain E, Harrell F, et al.
J Clin Transl Sci
. 2024 Dec;
8(1):e177.
PMID: 39619071
[This corrects the article DOI: 10.1017/cts.2024.514.].
3.
Lindsell C, Shotwell M, Anstrom K, Berry S, Brittain E, Harrell F, et al.
J Clin Transl Sci
. 2024 Nov;
8(1):e155.
PMID: 39540110
The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Cross-Trial Statistics Group gathered lessons learned from statisticians responsible for the design and analysis of the 11 ACTIV therapeutic master protocols to...
4.
Tian Y, Li C, Tu S, James N, Harrell F, Shepherd B
J Am Stat Assoc
. 2024 Oct;
119(546):864-874.
PMID: 39463921
Detection limits (DLs), where a variable cannot be measured outside of a certain range, are common in research. DLs may vary across study sites or over time. Most approaches to...
5.
Heinze G, Baillie M, Lusa L, Sauerbrei W, Schmidt C, Harrell F, et al.
BMC Med Res Methodol
. 2024 Aug;
24(1):178.
PMID: 39117997
Statistical regression models are used for predicting outcomes based on the values of some predictor variables or for describing the association of an outcome with predictors. With a data set...
6.
Freiberg J, Siemann J, Qian E, Ereshefsky B, Hennessy C, Stollings J, et al.
Res Sq
. 2024 Jul;
PMID: 38947088
Background: Vancomycin, an antibiotic with activity against Methicillin-resistant (MRSA), is frequently included in empiric treatment for community-acquired pneumonia (CAP) despite the fact that MRSA is rarely implicated in CAP. Conducting...
7.
Foley M, Rajkumar C, Ahmed-Jushuf F, Simader F, Chotai S, Pathimagaraj R, et al.
Lancet
. 2024 Apr;
403(10436):1543-1553.
PMID: 38604209
Background: The coronary sinus reducer (CSR) is proposed to reduce angina in patients with stable coronary artery disease by improving myocardial perfusion. We aimed to measure its efficacy, compared with...
8.
Maiga A, Cook M, Nordness M, Gao Y, Rakhit S, Rivera E, et al.
J Am Coll Surg
. 2024 Jan;
238(4):589-597.
PMID: 38214447
Background: The Glasgow Outcome Scale Extended (GOSE) is a measure of recovery after traumatic brain injury (TBI). Public surveys rate some GOSE states as worse than death. Direct family experience...
9.
Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension
Caccamo M, Harrell F, Hemnes A
Pulm Circ
. 2023 Aug;
13(3):e12271.
PMID: 37554146
Selection of endpoints for clinical trials in pulmonary arterial hypertension (PAH) is challenging because of the small numbers of patients and the changing expectations of patients, clinicians, and regulators in...
10.
Master H, Annis J, Huang S, Beckman J, Ratsimbazafy F, Marginean K, et al.
Nat Med
. 2023 Apr;
29(12):3270.
PMID: 37046000
No abstract available.